Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.
about
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cellsEpigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cellsCurrent approaches in identification and isolation of human renal cell carcinoma cancer stem cellsEpigenetics meets radiation biology as a new approach in cancer treatmentTurning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.Transforming growth factor β as regulator of cancer stemness and metastasisStem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerFrom hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanismsTransforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblastsConstitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesisResponse to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host miceSignificance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.Epigenetic reprogramming modulates malignant properties of human liver cancer.Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristicsTGF-β mediated DNA methylation in prostate cancer.Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.Clinical implications of cancer stem cell biology in hepatocellular carcinoma.Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasionG protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinomaInhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cellsHepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathwayEpigenetic regulation of inflammatory cytokines and associated genes in human malignanciesDNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinomaTGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.Stem cells in liver diseases and cancer: recent advances on the path to new therapies.The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.Role of epigenetic modifications in luminal breast cancer.Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers.Bone morphogenetic protein-7 regulates Snail signaling in carbon tetrachloride-induced fibrosis in the rat liver.Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.Cancer stem cells in the development of liver cancerCancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.
P2860
Q21559479-F8FED2AB-16E0-4177-9FB4-603F09ABDF89Q24629061-9D089F6C-4FAC-4DEC-9FD3-FB35B3E4EE4FQ26786047-604068F5-DAFA-4C35-BD27-6A39CC612734Q27014984-AA842B99-90AC-4725-8A59-0B12DC755E5CQ27692697-D7C39954-1F2B-4299-B80B-9EEF1116A5C8Q28077319-032E2380-99E9-4EBC-856A-CB10C4C14322Q28079205-2E9A528E-A81F-46BD-86A4-477CBE560C0FQ28383729-20899884-9327-4AB3-9F0C-78C1A314FED7Q28583952-59C572B9-9537-411E-BC7D-30A7F88DFEE2Q30354729-B0F12ADF-2055-4762-88F8-334803E2F24AQ31115121-9D815A8D-8FEB-4775-A094-76CA5B485B07Q33562298-CA1A4225-7739-476A-AD00-C6792732A817Q33637249-BC9CA14F-1A04-4B14-BF23-3FF2101EE31DQ33707196-63A3FAC0-7EE8-4520-82CA-7371D457308FQ33729015-F7572DF8-3324-4F36-B1FF-4B6C02661B11Q33806379-DF99EDAB-9853-4371-8C81-767A882CF080Q33872467-C729052E-1D30-4D4B-A063-84873559714CQ34022318-868DA73C-DC40-4B5F-B01F-67185FFFD915Q34039935-29BE1CCF-1401-4A10-B9F7-52EDE01D52E3Q34092485-9C880F09-83ED-45C8-937B-006D9B85F376Q34357073-8D407CD2-189C-44EF-B41D-911A471D05BAQ34545548-4232F06B-484C-47DA-BE5C-D5050AB646CCQ34674548-782DDC72-5DD3-45CD-9EDF-504D67370C60Q34786517-379D2F6C-C486-445F-A69F-2F810BBA9E17Q34983695-05AC285C-59BE-461B-BC4D-824147E061D2Q35076779-BE5E0774-CE2E-4B0F-BAC2-CE36CB799D84Q35178132-7362572D-FA10-4FDD-A348-D11B92AD99C8Q35197356-81B55048-1836-4115-AB75-DC3561E8EBA7Q35235798-15E73D32-75FA-4468-8C37-03F6F3B572A4Q35273414-0A96FBE7-7A83-4A2C-8948-94AA66EE3C07Q35631841-431904A0-41B6-4E62-895A-C332D7E5813CQ35636713-EB8B02BD-9986-465D-8762-584A6079F345Q35963443-187DE7C9-BCB6-4901-BFDF-686C0843F82BQ35995560-721D1742-2741-46AD-AF05-6E576FCC2235Q36349927-23F3B247-D348-479D-957A-BC13310AFFDAQ36372971-576E1DF6-924C-42C1-813E-2AE55F576D47Q36386667-C34F4B93-3420-4482-943E-7FF9BFAF6344Q36619069-EB601FB1-16B9-4A26-B25B-C5571B5517EEQ36793453-4FC39255-1822-4FD7-8BCD-DAEB709BFAA3Q36796375-C88EF503-D451-4BC2-95B8-93088E145F1E
P2860
Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@ast
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@en
type
label
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@ast
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@en
prefLabel
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@ast
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@en
P2093
P2860
P356
P1433
P1476
Epigenetic regulation of cance ...... ansforming growth factor-beta.
@en
P2093
C Bart Rountree
Hanning You
P2860
P304
P356
10.1002/HEP.23544
P407
P577
2010-05-01T00:00:00Z